BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 28/10/2005

Oncologic Drugs Advisory Committee to Review and Revise Notice Regarding New Cancer Treatment

The Oncologic Drugs Advisory Committee will review and revise a notice related to a new cancer treatment, following a recent proposal by the FDA to update the notice

Source: Federal Register — Food and Drug AdministrationOpen original release →